Pentracor Gmbh

Christopher Bock

Ahmed Sheriff

Birgit Vogt

The present invention relates to an apheresis device () for the extracorporeal removal of C-reactive protein from blood of a patient, wherein the apheresis device is connectable to the blood circulation of the patient. The blood is pumped via a part of the extracorporeal circulation system () of the apheresis device () according to the invention to a cell separator () for separation of the blood into blood plasma and cellular components. Via a first outlet of the cell separator (), the separated blood plasma is directed by means of a plasma line (A) to an apheresis column () for affinity chromatographic removal of C-reactive protein from the blood plasma. After removal of the C-reactive protein from the blood plasma of the patient, said now treated blood plasma is combined with the cellular components of the blood via a plasma line (B). Furthermore, the apheresis device () according to the invention comprises a bypass line (), which leads from the plasma line (A) into the plasma line (B) while bypassing the apheresis column (). The apheresis device () according to the invention also comprises a regeneration line (), which runs into the plasma line (A) or directly into the apheresis column ().

Growing community of inventors

Berlin, Germany

Christopher Bock